Lin-Hao Zhang
Overview
Explore the profile of Lin-Hao Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang L, Li M, Wang D, Jin X, Chen F, Piao H
Molecules
. 2022 Nov;
27(22).
PMID: 36432026
(1) Background: Nuclear factor κB (NF-κB) is an important transcriptional regulator that regulates the inflammatory pathway and plays a key role in cellular inflammatory and immune responses. The presence of...
2.
Wang D, Li Y, Zhang L, Lv L, Zhao Y, Jin X, et al.
Bioorg Med Chem Lett
. 2020 Nov;
30(24):127652.
PMID: 33130293
Hypoxia-inducible factor 1α (HIF-1α) is a known regulator of tumor cell proliferation, migration, and angiogenesis. The presence of a high concentration of HIF-1α is positively correlated with the severity of...
3.
Zhang L, Jin L, Liu F, Jin C, Jin C, Wei Z
Exp Parasitol
. 2020 Jun;
216:107935.
PMID: 32569599
Toxoplasma gondii is an important pathogen that causes serious public health problems. Currently, therapeutic drugs for toxoplasmosis cause serious side effects, and more effective and novel substances with relatively low...
4.
Huang Z, Zhang L, Zhao C, Liu R, Tong H, Gan C, et al.
Int J Clin Exp Pathol
. 2020 Jan;
11(12):5635-5646.
PMID: 31949650
Hypoxia inducible factor 1 alpha subunit (HIF-1α) is induced in hypoxic conditions and plays a crucial role in the neoangiogenesis and metastasis of cancer. In this study, we aimed to...
5.
Tai Y, Zhang L, Gao J, Zhao C, Tong H, Ye C, et al.
Cancer Manag Res
. 2019 May;
11:2831-2848.
PMID: 31114336
Biomarkers are lacking in hepatocellular carcinoma (HCC). Cyclooxygenase-2 (COX-2) and its metabolites play crucial roles in the process of inflammation-tumor transformation. This study was aimed to detect COX-2 expression in...
6.
Zhang L, Zhang Z, Li M, Wei Z, Jin X, Piao H
Bioorg Med Chem Lett
. 2019 Apr;
29(12):1440-1445.
PMID: 31006525
The hypoxia-inducible factor-1α (HIF-1α) pathway has been implicated in tumor angiogenesis, growth, and metastasis. Therefore, the inhibition of this pathway is an important therapeutic target for the treatment of various...
7.
Wu J, Zhang Z, Zhang L, Jin X, Ma J, Piao H
Bioorg Med Chem Lett
. 2019 Feb;
29(6):853-858.
PMID: 30728113
The transcription factor hypoxia-inducible factor-1α (HIF-1α) plays an important role in tumor angiogenesis, growth, and metastasis and is recognized as an important potential therapeutic target for cancer. Here, we designed...
8.
Tong H, Tai Y, Ye C, Wu H, Zhang L, Gao J, et al.
Oncotarget
. 2017 Nov;
8(44):78068-78075.
PMID: 29100448
Tumor markers could increase in both tuberculous peritonitis and peritonitis carcinomatosa, confusing the differentiation of these diseases. This study aimed to better understand the extent of elevation and diagnostic efficacies...
9.
Zhang L, Tong H, Wei B, Wu H, Tang C
Chin Med J (Engl)
. 2017 Aug;
130(16):1999-2000.
PMID: 28776556
No abstract available.
10.
Tong H, Wei B, Chen S, Xie Y, Zhang M, Zhang L, et al.
Oncotarget
. 2017 Apr;
8(29):48303-48312.
PMID: 28430638
Recurrence of hepatocellular carcinoma (HCC) after transarterial chemoembolisation (TACE) is common due to neoangiogenesis. Cyclooxygenase-2 inhibitors and somatostatin analogues were reported to inhibit tumour angiogenesis. The pilot randomized controlled trial...